Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) just unveiled an update.
Lifecare ASA has achieved a significant milestone with the successful implantation of the first device from a new production batch of its implantable Continuous Glucose Monitoring technology. This advancement demonstrates the company’s ability to reproducibly manufacture high-quality, implantable devices under an updated production protocol, marking a transition from technology development to execution. This development supports Lifecare’s progress towards entering the veterinary market and advancing future clinical programs.
More about Lifecare AS
Lifecare ASA is a MedTech company specializing in the development of next-generation Continuous Glucose Monitoring (CGM) systems. The company focuses on using osmotic pressure as a sensing principle to monitor various body analytes, aiming to bring advanced CGM technology to both human and veterinary markets.
Average Trading Volume: 108,246
Current Market Cap: NOK84.82M
Learn more about LFC0 stock on TipRanks’ Stock Analysis page.